The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
Tsai TF, Ho V, Song M, Szapary P, Kato T, Wasfi Y, Li S, Shen YK, Leonardi C; PHOENIX 1, PHOENIX 2, ACCEPT, PEARL and Japanese Ustekinumab Study Groups.
Tsai TF, et al. Among authors: wasfi y.
Br J Dermatol. 2012 Nov;167(5):1145-52. doi: 10.1111/j.1365-2133.2012.11142.x.
Br J Dermatol. 2012.
PMID: 22803615
Clinical Trial.